Your browser doesn't support javascript.
loading
Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease.
Silbernagel, Günther; Scharnagl, Hubert; Kleber, Marcus E; Hoffmann, Michael M; Delgado, Graciela; Stojakovic, Tatjana; Gary, Thomas; Zeng, Lingyao; Ritsch, Andreas; Zewinger, Stephen; Speer, Thimoteus; Schunkert, Heribert; Landmesser, Ulf; März, Winfried; Grammer, Tanja B.
Afiliação
  • Silbernagel G; Division of Angiology, Department of Internal Medicine, Medical University of Graz, Austria; Department of Cardiology, Charité-Universitätsmedizin Berlin (CBF), Berlin Institute of Health (BIH), DZHK (German Center for Cardiovascular Research) e.V., Partner Site Berlin, Berlin, Germany.
  • Scharnagl H; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. Electronic address: hubert.scharnagl@medunigraz.at.
  • Kleber ME; Department of Internal Medicine 5 (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
  • Hoffmann MM; Institute of Clinical Chemistry and Laboratory Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Delgado G; Department of Internal Medicine 5 (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
  • Stojakovic T; Clinical Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Graz, Graz, Austria.
  • Gary T; Division of Angiology, Department of Internal Medicine, Medical University of Graz, Austria.
  • Zeng L; Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, DZHK (German Center for Cardiovascular Research) e.V., Partner Site Munich Heart Alliance, Munich, Germany.
  • Ritsch A; Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.
  • Zewinger S; Department of Internal Medicine 4 (Nephrology and Hypertension), University of Homburg, Homburg/Saar, Germany.
  • Speer T; Department of Internal Medicine 4 (Nephrology and Hypertension), University of Homburg, Homburg/Saar, Germany.
  • Schunkert H; Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, DZHK (German Center for Cardiovascular Research) e.V., Partner Site Munich Heart Alliance, Munich, Germany.
  • Landmesser U; Department of Cardiology, Charité-Universitätsmedizin Berlin (CBF), Berlin Institute of Health (BIH), DZHK (German Center for Cardiovascular Research) e.V., Partner Site Berlin, Berlin, Germany.
  • März W; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria; Department of Internal Medicine 5 (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany; Synlab Acade
  • Grammer TB; Mannheimer Institute for Public Health, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
Atherosclerosis ; 311: 84-90, 2020 10.
Article em En | MEDLINE | ID: mdl-32949947

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Hipertrigliceridemia Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Hipertrigliceridemia Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha